SEC ownership of bluebird bio, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001293971.

Comparable stake leader

Jason Cole

Disclosed value leader

Jason Cole

Comparable rows

0/20

Latest evidence

02 Jun 2025

Ownership snapshot 1 signal
Latest evidence date
02 Jun 2025
Issuer identity 2 identity fields
CIK
0001293971
Location
Somerville, MA

Ownership snapshot

Top shareholders of bluebird bio, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Jason Cole
Disclosed value leader
Jason Cole
Comparable rows
0/20
Latest evidence
02 Jun 2025
3/4/5 Highest disclosed value: $270,937 20 rows are not safely comparable across share classes. Showing 1-8 of 20 holder rows.

Quick read

Jason Cole has the largest disclosed position value at $270.9K.

0 of 20 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Disclosed position value Top 5
Jason Cole $270.9K
Gina Consylman $179.2K
Jessica Whitten $81.4K
Christopher Krawtschuk $65K
Anne-Virginie Eggimann $60.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-8 of 20 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Jason Cole
3/4/5
Chief Strategy & Financial Off
class O/S missing
$270,937
189,546 shares
19 Aug 2022
Gina Consylman
3/4/5
Chief Financial Officer
mixed-class rows
$179,225
175,385 shares
mixed-class rows
01 Feb 2022
Jessica Whitten
3/4/5
Chief Accounting Officer
mixed-class rows
$81,351
71,913 shares
mixed-class rows
01 Feb 2022
Christopher Krawtschuk
3/4/5
Chief Financial Officer
mixed-class rows
$65,001
244,474 shares
mixed-class rows
01 Mar 2024
Anne-Virginie Eggimann
3/4/5
Chief Regulatory Officer
class O/S missing
$60,395
42,252 shares
12 Jul 2022
Philip D. Gregory
3/4/5
Chief Scientific Officer
class O/S missing
$48,781
34,127 shares
11 Nov 2021
William D. Baird III
3/4/5
Chief Financial Officer
class O/S missing
$32,586
22,797 shares
11 Nov 2021
Wendy L. Dixon
3/4/5
Director
mixed-class rows
$17,001
21,932 shares
mixed-class rows
11 Nov 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 27 reporting-owner rows connected to bluebird bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
27
Largest current holder
Jason Cole
Net 12M change
$0
Latest report
02 Jun 2025
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Jason Cole Chief Strategy & Financial Off $270,937 Mixed 19 Aug 2022
Gina Consylman Chief Financial Officer $179,225 Mixed 01 Feb 2022
Jessica Whitten Chief Accounting Officer $81,351 Mixed 01 Feb 2022
Christopher Krawtschuk Chief Financial Officer $65,001 Mixed 01 Mar 2024
Anne-Virginie Eggimann Chief Regulatory Officer $60,395 Mixed 12 Jul 2022
Philip D. Gregory Chief Scientific Officer $48,781 Mixed 11 Nov 2021
William D. Baird III Chief Financial Officer $32,586 Mixed 11 Nov 2021
Wendy L. Dixon Director $17,001 Mixed 11 Nov 2021
Daniel Lynch Director $11,377 Mixed 11 Nov 2021
William R. Sellers Director $5,147 Mixed 11 Nov 2021
Denice Torres Director $3,897 Mixed 11 Nov 2021
Thomas J. Klima Chief Commercial & Operating Officer $0 Mixed 30 May 2025
Joseph Vittiglio Chief Business & Legal Officer $0 Mixed 30 May 2025
Andrew Obenshain President and CEO, Director $0 Mixed 30 May 2025
Mark Vachon Director $0 Mixed 30 May 2025
Agwunobi John O Director $0 Mixed 30 May 2025
Michael Cloonan Director $0 Mixed 02 Jun 2025
Elisabeth Leiderman Director $0 Mixed 30 May 2025
O James Sterling Chief Financial Officer $0 Mixed 02 Jun 2025
Richard A. Paulson Director $0 Mixed 30 May 2025

Recent insider transactions for bluebird bio, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Joseph Vittiglio BLUE Common Stock Award 2,500 2,500 02 Jun 2025 Direct
Joseph Vittiglio BLUE Common Stock Disposed to Issuer -100% -5,625 0 02 Jun 2025 Direct
John O Agwunobi BLUE Common Stock Disposed to Issuer -100% -1,245 0 02 Jun 2025 Direct
Mark Vachon BLUE Common Stock Disposed to Issuer -100% -1,245 0 02 Jun 2025 Direct
Richard A. Colvin BLUE Common Stock Award 2,500 2,500 02 Jun 2025 Direct
Richard A. Colvin BLUE Common Stock Disposed to Issuer -100% -6,666 0 02 Jun 2025 Direct
Najoh Tita-Reid BLUE Common Stock Disposed to Issuer -100% -1,245 0 02 Jun 2025 Direct
Andrew Obenshain BLUE Common Stock Award 14,820 14,820 02 Jun 2025 Direct
Andrew Obenshain BLUE Common Stock Disposed to Issuer -100% -24,120 0 02 Jun 2025 Direct
Elisabeth Leiderman BLUE Common Stock Disposed to Issuer -100% -1,245 0 02 Jun 2025 Direct
Charlotte Jones-Burton BLUE Common Stock Disposed to Issuer -100% -1,245 0 02 Jun 2025 Direct
Thomas J. Klima BLUE Common Stock Award 2,500 2,500 02 Jun 2025 Direct
Thomas J. Klima BLUE Common Stock Disposed to Issuer -100% -6,964 0 02 Jun 2025 Direct
O James Sterling BLUE Common Stock Award 2,500 2,500 02 Jun 2025 Direct
O James Sterling BLUE Common Stock Disposed to Issuer -100% -7,500 0 02 Jun 2025 Direct
Nick Leschly BLUE Common Stock Disposed to Issuer -100% -1,245 0 02 Jun 2025 Direct
Richard A. Paulson BLUE Common Stock Disposed to Issuer -100% -1,323 0 02 Jun 2025 Direct
Michael Cloonan BLUE Common Stock Disposed to Issuer -100% -1,867 0 02 Jun 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .